Moreover, they reported a correlation with stroke severity, with ICAM-1+ EVs (CD105+, CD54+, CD45– (leukocyte marker)) being most strongly correlated with infarct volume and endoglin+ EVs (CD105+, CD41a–, CD45–) correlating with long-term clinical outcome. This evidence concerns the gene PTPRC and stroke disorder.